April 23, 2026 Genetic Variants Linked to Better Response to GLP-1 Medications for Obesity, Enabling Precision Treatment Approaches
April 23, 2026 Understanding the Link Between Obesity, Diabetes, and Liver Disease: Expert Insights on Prevention, Exercise, and Lifestyle Changes for Better Liver Health
April 22, 2026 Expanding Access to GLP-1s in Medicare and Medicaid: CMS Initiatives, the BALANCE Model, and Implications for Beneficiaries and Budgets
March 31, 2026 Project Remission: New Film Series Highlights Lifestyle Medicine for Type 2 Diabetes Reversal
February 25, 2026 Novo Nordisk’s UBT251: Promising New Weight Loss Drug Shows 20% Weight Loss in Trial
